EC Healthcare's (HKG:2138) subsidiary, Jade Master International, completed the sale of its 51% stake in New Medical Centre to AIA Hong Kong Medical Services on Friday, a Monday Hong Kong bourse filing said.
The transaction was first announced in November 2024, with Jade Master agreeing to dispose of the majority stake for HK$437.6 million.
The company also completed the acquisition of a 40% stake in its unit, Hong Kong Medical Advanced Imaging (TST), as part of an internal reorganization within the group.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.